Bimekizumab infection rates in patients with moderate to severe plaque psoriasis: Analysis of pooled data from 2 years of treatment in phase 3 and 3b clinical trials

N/A

Saved in:
Bibliographic Details
Published inSkin (Milwood, N.Y.) Vol. 6; no. 6; p. s72
Main Authors Armstrong, A, Langley, RG, Gordon, KB, Warren, RB, Thaçi, D, Stein Gold, L, Peterson, L, Madden, C, Nunez Gomez, N, De Cuyper, D, Costanzo, A
Format Journal Article
LanguageEnglish
Published 16.11.2022
Online AccessGet full text

Cover

More Information
Summary:N/A
ISSN:2574-1624
2574-1624
DOI:10.25251/skin.6.supp.72